Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-25 @ 4:27 AM
NCT ID:
NCT02271620
Eligibility Criteria:
Inclusion Criteria:
* Children 8-15 years who were diagnosed with nonallergic rhinitis (NAR) at least 1 year
* No respiratory infections in the previous 4 weeks
* No following treatment of
* systemic corticosteroid 4 weeks
* intranasal corticosteroid 2 weeks
* oral antihistamine 1 week
* leukotriene antagonist 1 week
Exclusion Criteria:
* Patients with underlying disease:
* chronic rhinosinusitis and nasal polyp
* immunological disease
* chronic renal disease
* hepatobiliary disease
* cardiovascular disease
* cancer
* Parental withdraw consent
* Patient with uncontrolled asthma, peak expiratory flow rate (PEFR) \< 80% of predicted
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
18 Years
Study:
NCT02271620
Study Brief:
Protocol Section:
NCT02271620